Direct-to-Digital Pathology Platform
Oncology Surgical Margin Screening, Primary Diagnosis, Clinical Research
Pre-clinicalActive
Key Facts
Indication
Oncology Surgical Margin Screening, Primary Diagnosis, Clinical Research
Phase
Pre-clinical
Status
Active
Company
About SurgiVance
SurgiVance is pioneering a direct-to-digital pathology platform designed to transform surgical and diagnostic oncology workflows. Its integrated system, featuring a point-of-care tabletop imager, AI software, and proprietary disposables, generates pathology-grade digital images in under 60 seconds without calibration. The company targets critical applications in surgical margin screening, primary diagnosis, and clinical research, positioning itself at the foundation of future AI-enhanced diagnostic ecosystems. Backed by notable industry advisors, SurgiVance is addressing the slow, analog bottlenecks in traditional pathology.
View full company profile